Investigation of the Prevalence of HBsAg, Anti-HCV, and Anti-HIV in a Prison in Turkey: A Point Prevalence Study
-
Published:2023-12-26
Issue:3
Volume:29
Page:119-123
-
ISSN:1307-9441
-
Container-title:Viral Hepatitis Journal
-
language:
-
Short-container-title:vhd
Author:
Mutlu Yılmaz EsmerayORCID, Bilgin MelekORCID, Şentürk Köksal ZeynepORCID, Oruç Muhammet AliORCID, Tabak FehmiORCID
Publisher
Galenos Yayinevi
Reference29 articles.
1. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis;Larney;Hepatology,2013 2. 2. Kwon JA, Chambers GM, Luciani F, Zhang L, Kinathil S, Kim D, Thein HH, Botha W, Thompson S, Lloyd A, Yap L, Gray RT, Butler T. Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis. Plos one 2021;16:e0245896. 3. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey;Long;BMJ,2001 4. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort;JJ;J Infect Dis,2004 5. 5. Søholm J, Holm DK, Mössner B, Madsen LW, Hansen JF, Weis N, Sauer AP, Awad T, Christensen PB. Incidence, prevalence and risk factors for hepatitis C in Danish prisons. PloS one 2019;14:e0220297.
|
|